Testosterone castration levels in patients with prostate cancer: Is there a difference between GnRH agonist and GnRH antagonist? Primary results of an open-label randomized control study

Purpose: To compare testosterone castration levels between patients treated with the gonadotropin-releasing hormone (GnRH) antagonist, degarelix, and GnRH agonist. Materials and Methods: Patients with prostate cancer (PCa) of a single outpatient clinic were randomized (2:1) to receive degarelix (gr...

詳細記述

書誌詳細

主要な著者:	Vaios-Konstantinos Mytilekas, Efstathios Papaefstathiou, Periklis Koukourikis, Xenofon Ouzounidis, Stavros Kazantzidis, Konstantinos Hatzimouratidis
フォーマット:	Artigo
言語:	Inglês
出版事項:	Korean Urological Association 2023-11-01
シリーズ:	Investigative and Clinical Urology
主題:	androgen deprivation therapy prostate cancer testosterone
オンライン･アクセス:	https://www.icurology.org/pdf/10.4111/icu.20230027
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!